scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1007/S11064-006-9251-3 |
P698 | PubMed publication ID | 17342413 |
P2093 | author name string | Barry D Jordan | |
P2860 | cites work | Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta) | Q67482080 |
The angiotensin I-converting enzyme | Q70171578 | ||
A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele | Q72319861 | ||
Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias | Q73172415 | ||
Apolipoprotein E and functional recovery from brain injury following postacute rehabilitation | Q73230751 | ||
Association of an interleukin 1 alpha polymorphism with Alzheimer's disease | Q74207122 | ||
Lower cognitive performance of older football players possessing apolipoprotein E epsilon4 | Q74300750 | ||
Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro | Q74371507 | ||
Effect of apolipoprotein E genotype on hematoma volume after trauma | Q77500805 | ||
Traumatic brain injury induces biphasic upregulation of ApoE and ApoJ protein in rats | Q81105969 | ||
Intrathecal administration of a novel apoE-derived therapeutic peptide improves outcome following perinatal hypoxic-ischemic injury | Q81751466 | ||
Lack of association between the IL1A gene (-889) polymorphism and outcome after head injury | Q82087307 | ||
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease | Q22248076 | ||
Chronic Traumatic Brain Injury Associated with Boxing | Q22250925 | ||
Association of interleukin-1 gene polymorphisms with dementia in a community-based sample: The Honolulu-Asia Aging Study | Q24170139 | ||
Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease | Q24308731 | ||
Catechol-O-methyltransferase polymorphisms and some implications for cognitive therapeutics | Q24608073 | ||
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families | Q27860677 | ||
Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine | Q28202137 | ||
A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes | Q28253913 | ||
beta-Trefoil fold. Patterns of structure and sequence in the Kunitz inhibitors interleukins-1 beta and 1 alpha and fibroblast growth factors | Q28294610 | ||
Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury | Q28296348 | ||
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease | Q29614952 | ||
Replication validity of genetic association studies | Q29615456 | ||
There is no evidence of an association in children and teenagers between the apolipoprotein E epsilon4 allele and post-traumatic brain swelling | Q30772211 | ||
Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity | Q31017305 | ||
Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase | Q33636637 | ||
Head injury and the risk of AD in the MIRAGE study | Q33880873 | ||
Apolipoprotein E in the brain and its role in Alzheimer's disease | Q33921712 | ||
Apoptosis after traumatic brain injury | Q34076438 | ||
Problems of reporting genetic associations with complex outcomes | Q34184173 | ||
The p53 tumor suppressor: critical regulator of life & death in cancer | Q34230676 | ||
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels | Q34262228 | ||
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease | Q34662682 | ||
Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels | Q35196218 | ||
The ACE gene and Alzheimer's disease susceptibility | Q35435738 | ||
Long term neuropsychological outcome after head injury: relation to APOE genotype | Q35475360 | ||
Is there a relation between APOE expression and brain amyloid load in Alzheimer's disease? | Q35488917 | ||
Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice | Q35809803 | ||
Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro | Q35834037 | ||
Influence of APOE polymorphism on cognitive and behavioural outcome in moderate and severe traumatic brain injury | Q36142443 | ||
Association of APOE e4 and cerebrovascular pathology in traumatic brain injury | Q36142917 | ||
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease | Q36604545 | ||
Association of interleukin-1 gene polymorphisms with Alzheimer's disease | Q37324133 | ||
Effects of closed traumatic brain injury and genetic factors on the development of Alzheimer's disease. | Q38458256 | ||
Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury | Q53200531 | ||
Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease. | Q53204218 | ||
Apolipoprotein-epsilon4 and head trauma: Synergistic or additive risks? | Q53211330 | ||
Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism. | Q53233667 | ||
Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype. | Q53237533 | ||
Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model. | Q53341374 | ||
Perspective on a pathogenesis and treatment of Alzheimer's disease. | Q53600765 | ||
Association of apolipoprotein E polymorphism with outcome after head injury. | Q53777504 | ||
Influence of Angiotensin-Converting Enzyme Polymorphism on Neuropsychological Subacute Performance in Moderate and Severe Traumatic Brain Injury | Q57305194 | ||
The association between APOE ε4, age and outcome after head injury: a prospective cohort study | Q57403309 | ||
Effect of the angiotensin I-converting enzyme I/D polymorphism on cognitive decline☆ | Q57605994 | ||
ApoE as a prognostic factor for post–traumatic coma | Q58451995 | ||
Apolipoprotein E allele-dependent antioxidant activity in brains with Alzheimer's disease | Q39507607 | ||
Head trauma and risk of dementia and Alzheimer's disease: The Rotterdam Study | Q39524796 | ||
Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele | Q39652460 | ||
Codon 72 polymorphism of the TP53 gene | Q40522948 | ||
Profile of gene expression in the subventricular zone after traumatic brain injury | Q40545439 | ||
The codon 72 polymorphic variants of p53 have markedly different apoptotic potential | Q40672888 | ||
Apolipoprotein E protects against NMDA excitotoxicity | Q40686205 | ||
Amyloid beta-protein, APOE genotype and head injury | Q40983097 | ||
Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene | Q41064715 | ||
A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro | Q43458583 | ||
The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment | Q43501718 | ||
A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition | Q43941587 | ||
Contribution of APOE promoter polymorphisms to Alzheimer's disease risk | Q43998196 | ||
The angiotensin I converting enzyme gene as a susceptibility factor for dementia | Q44010531 | ||
Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics | Q44282697 | ||
Protective effect of apolipoprotein E-mimetic peptides on N-methyl-D-aspartate excitotoxicity in primary rat neuronal-glial cell cultures. | Q44297276 | ||
Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. | Q44376527 | ||
Correlation between transcranial interleukin-6 gradient and outcome in patients with acute brain injury | Q44467529 | ||
Association between the interleukin-1alpha gene and Alzheimer's disease: a meta-analysis | Q44498709 | ||
Association between apolipoprotein E genotype and outcome of traumatic brain injury | Q44603568 | ||
Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro | Q45081026 | ||
Effect of the dopamine D2 receptor T allele on response latency after mild traumatic brain injury | Q46078598 | ||
Alzheimer disease risk and genetic variation in ACE: a meta-analysis | Q46122130 | ||
Increased apolipoprotein E mRNA in the hippocampus in Alzheimer disease and in rats after entorhinal cortex lesioning | Q46163083 | ||
ACE genotype and cognitive decline in an African-Caribbean population | Q46493106 | ||
Relationship between the Arg72Pro polymorphism of p53 and outcome for patients with traumatic brain injury | Q46593008 | ||
Apolipoprotein E polymorphism and outcome after closed traumatic brain injury: influence of ethnic and regional differences | Q46867012 | ||
Association of COMT Val158Met genotype with executive functioning following traumatic brain injury | Q46875336 | ||
Raised parenchymal interleukin-6 levels correlate with improved outcome after traumatic brain injury | Q47360569 | ||
APOE influences on neuropsychological function after mild head injury: within-person comparisons | Q47376629 | ||
Genetic variation of the APOE promoter and outcome after head injury | Q47636791 | ||
ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory | Q48233701 | ||
Antioxidant mechanisms in apolipoprotein E deficient mice prior to and following closed head injury | Q48249292 | ||
Hippocampal volume, brain atrophy, and APOE genotype after traumatic brain injury | Q48423299 | ||
Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease. | Q48438753 | ||
Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition | Q48601482 | ||
Influence of Angiotensin-converting enzyme polymorphism on neuropsychological subacute performance in moderate and severe traumatic brain injury | Q48624215 | ||
Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury | Q48624330 | ||
APOE genotype influences acquisition and recall following traumatic brain injury | Q48636055 | ||
Apolipoprotein E epsilon 4 and short-term recovery from predominantly mild brain injury | Q48636101 | ||
Apolipoprotein E ∈4 Associated With Chronic Traumatic Brain Injury in Boxing | Q48659275 | ||
IL-1RN and IL-1B gene polymorphisms and cerebral hemorrhagic events after traumatic brain injury | Q48736047 | ||
D2 dopamine receptor A1 allele in Alzheimer disease and aging | Q48787919 | ||
Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer's disease. | Q48791581 | ||
Association between interleukin-1 beta (IL-1beta) gene polymorphism and outcome after head injury: an early report | Q48887259 | ||
A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury | Q49071765 | ||
Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: the allele E3 is neuroprotective whereas E4 increases fatalities | Q49160372 | ||
Head injury and risk of Alzheimer's disease by apolipoprotein E genotype. | Q50936085 | ||
APOE-epsilon4 predicts dementia but not other psychiatric disorders after traumatic brain injury. | Q51938099 | ||
Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. | Q52051272 | ||
Six-month recovery from mild to moderate Traumatic Brain Injury: the role of APOE-epsilon4 allele. | Q52547169 | ||
P433 | issue | 4-5 | |
P921 | main subject | traumatic brain injury | Q1995526 |
P304 | page(s) | 905-915 | |
P577 | publication date | 2007-03-07 | |
P1433 | published in | Neurochemical Research | Q15716728 |
P1476 | title | Genetic influences on outcome following traumatic brain injury | |
P478 | volume | 32 |
Q39632602 | A neuroscientific approach to the examination of concussions in student-athletes |
Q51010658 | APOE genotype and neuropsychological outcome in mild-to-moderate traumatic brain injury: a pilot study. |
Q33972402 | APOE polymorphisms and cognitive functions in patients with brain tumors |
Q35237359 | Addressing neuropsychiatric disturbances during rehabilitation after traumatic brain injury: current and future methods. |
Q41199235 | ApoE4-associated phospholipid dysregulation contributes to development of Tau hyper-phosphorylation after traumatic brain injury. |
Q49797086 | Apolipoprotein E (APOE) ε4 Genotype is Associated with Elevated Psychiatric Distress in Veterans with a History of Mild to Moderate Traumatic Brain Injury |
Q52147756 | Apolipoprotein E (APOE) ϵ4 Allele Is Associated with Increased Symptom Reporting Following Sports Concussion. |
Q30413990 | Apolipoprotein E polymorphisms and severity of cerebral palsy: a cross-sectional study in 255 children in Norway |
Q33657778 | Apolipoprotein E4 as a predictor of outcomes in pediatric mild traumatic brain injury |
Q34497951 | Apolipoprotein E: From lipid transport to neurobiology |
Q34680878 | Apolipoproteins in the brain: implications for neurological and psychiatric disorders |
Q38743997 | Applying Systems Biology Methodology To Identify Genetic Factors Possibly Associated with Recovery after Traumatic Brain Injury |
Q39045957 | Association of a common genetic variant within ANKK1 with six-month cognitive performance after traumatic brain injury |
Q34075655 | BDNF polymorphism predicts general intelligence after penetrating traumatic brain injury |
Q36279698 | Bench to bedside of neural stem cell in traumatic brain injury. |
Q35755981 | Biomarkers and genetics of brain injury risk in diabetic ketoacidosis: A pilot study |
Q50332309 | Biomarkers for cognitive decline in patients with diabetes mellitus: evidence from clinical studies. |
Q33666600 | Blast-related brain injury: imaging for clinical and research applications: report of the 2008 st. Louis workshop |
Q40793165 | COMT, BDNF, and DTNBP1 polymorphisms and cognitive functions in patients with brain tumors. |
Q34619302 | Chronic traumatic encephalopathy - neuropathology in athletes and war veterans |
Q36635100 | Chronic traumatic encephalopathy: the dangers of getting "dinged" |
Q53802856 | Common variants of APOE are associated with anti-epileptic drugs resistance in Han Chinese patients. |
Q34630618 | Considerations for animal models of blast-related traumatic brain injury and chronic traumatic encephalopathy |
Q45046735 | DRD2 C957T polymorphism is associated with improved 6-month verbal learning following traumatic brain injury |
Q34619997 | Drowning stars: reassessing the role of astrocytes in brain edema |
Q37732621 | Early prognosis in traumatic brain injury: from prophecies to predictions |
Q36946703 | Favorable outcomes for Native Hawaiians and other Pacific Islanders with severe traumatic brain injury |
Q50438138 | Gene co-expression networks identify Trem2 and Tyrobp as major hubs in human APOE expressing mice following traumatic brain injury. |
Q92700655 | Genetic Influences on Behavioral Outcomes After Childhood TBI: A Novel Systems Biology-Informed Approach |
Q37065825 | Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia |
Q30418386 | High interindividual variability in dose-dependent reduction in speed of movement after exposing C. elegans to shock waves. |
Q47136786 | Impact of Traumatic Brain Injury on Dopaminergic Transmission |
Q39096302 | Impact of traumatic brain injury on dopaminergic transmission |
Q55072902 | Influence of Concussion History and Genetics on Event-Related Potentials in Athletes: Potential Use in Concussion Management. |
Q33617258 | Macrophagic and microglial responses after focal traumatic brain injury in the female rat. |
Q34469376 | Mild traumatic brain injury and postconcussive symptoms in children and adolescents |
Q28391069 | Mitochondrial DNA and traumatic brain injury |
Q39035143 | Multimodal Imaging of Neurometabolic Pathology due to Traumatic Brain Injury |
Q46718853 | Need for More Traumatic Brain Injury Research: Response to Agrawal A. et al. Traumatic Brain Injury and Sleep Disturbances. J Clin Sleep Med 2008;4:177. |
Q37374171 | Polymorphisms in genes modulating the dopamine system: do they inf luence outcome and response to medication after traumatic brain injury? |
Q35886751 | Polymorphisms in the brain-derived neurotrophic factor gene influence memory and processing speed one month after brain injury |
Q26825547 | Predicting outcome after childhood brain injury |
Q38725668 | Predicting the outcome for individual patients with traumatic brain injury: a case-based review |
Q43552423 | Protective effects of mGluR5 positive modulators against traumatic neuronal injury through PKC-dependent activation of MEK/ERK pathway |
Q37625940 | Psychopharmacological issues in the treatment of TBI and PTSD. |
Q35659345 | Re-orientation of clinical research in traumatic brain injury: report of an international workshop on comparative effectiveness research |
Q48727880 | Relationship between the apolipoprotein E gene and headache following sports-related concussion |
Q33940053 | Review: Contact sport-related chronic traumatic encephalopathy in the elderly: clinical expression and structural substrates |
Q38064518 | Review: the long-term consequences of microglial activation following acute traumatic brain injury |
Q37294815 | Similar cation channels mediate protection from cerebellar exitotoxicity by exercise and inheritance. |
Q33758919 | Suicide, fatal injuries, and other causes of premature mortality in patients with traumatic brain injury: a 41-year Swedish population study |
Q54250305 | Susceptibility to Oxidative Stress Is Determined by Genetic Background in Neuronal Cell Cultures. |
Q34595620 | The associations of apolipoprotein E and angiotensin-converting enzyme polymorphisms and cognitive function in Type 1 diabetes based on an 18-year follow-up of the DCCT cohort |
Q64928904 | The potential roles of dopamine in traumatic brain injury: a preclinical and clinical update. |
Q38443987 | The role of apolipoprotein E episilon (ε)-4 allele on outcome following traumatic brain injury: A systematic review |
Search more.